What is Innoviva, Inc.'s ZEVTERA — revenue?

Innoviva, Inc. (INVA) reported ZEVTERA — revenue of $438K in Q1 2026.

What does ZEVTERA — revenue mean?

This metric represents the gross revenue generated from the sale or licensing of the ZEVTERA product line, excluding any pass-through taxes collected from customers. It serves as a key indicator of the commercial adoption and market penetration of this specific therapeutic asset within the company's infectious disease portfolio. Tracking this revenue stream allows investors to evaluate the growth trajectory and financial contribution of this critical care asset independently of the company's broader royalty-based income.

Innoviva, Inc. INVA ZEVTERA — Revenue

Similar metrics at other companies

HRO

HROWVEVYE — Revenue

$20.95M-2.6%

JAZZZiihera — Revenue from Contract with Customer, Excluding Assessed Tax

$13.3M+565%

JAZZZepzelca — Revenue from Contract with Customer, Excluding Assessed Tax

$101M+60.3%

HRO

HROWIHEEZO — Revenue

$1.85M-64.6%

URGNZusduri — Revenue

$29.25M—

GEOZA — Revenue

$5.52M+16.9%

Other financials

Income statement

See full

Revenue$98.0M+10.6%

Gross profit$75.8M+3.4%

Operating income$38.2M-7.9%

Net income$186.6M+501%

EPS (diluted)$2.22+400%

Balance sheet

See full

Cash & equivalents$603.1M+89.0%

Total debt$269.4M-40.3%

Total equity$1.3B—

Total assets$1.8B+46.4%

Cash flow

See full

Operating cash flow$35.3M-27.4%

CapEx$492.0K—

Free cash flow$34.8M-28.4%

Valuation

See full

Market cap$1.74B+51.8%

Profitability

See full

Gross margin73.7%-9.9pp

Operating margin38.1%-11.2pp

Net margin119.9%+107pp

FCF margin54.1%+5.3pp

Returns & leverage

See full

Return on equity29.1%—

Debt / equity0.2×—

Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s zevtera — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Innoviva, Inc.'s ZEVTERA — revenue?: Innoviva, Inc. (INVA) reported ZEVTERA — revenue of $438K in Q1 2026.
What does ZEVTERA — revenue mean?: This metric represents the gross revenue generated from the sale or licensing of the ZEVTERA product line, excluding any pass-through taxes collected from customers. It serves as a key indicator of the commercial adoption and market penetration of this specific therapeutic asset within the company's infectious disease portfolio. Tracking this revenue stream allows investors to evaluate the growth trajectory and financial contribution of this critical care asset independently of the company's broader royalty-based income.